International Stem Cell (ISCO) Net Margin (2010 - 2026)
International Stem Cell's Net Margin was -2.65% in Q2 2026, down 5.39 percentage points from 2.74% a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Net Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, International Stem Cell's Net Margin was -3.35% through Jun 30, 2026, down 0.06 percentage points year-over-year; for FY2025, it came in at -4.59%, down 2.29 percentage points from FY2024.
- Net Margin shows a five-year change of +33.62 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -2.30% in FY2024 (-0.62 pp), -1.68% in FY2023 (+2.36 pp), -4.05% in FY2022 (+8.48 pp) and -12.53% in FY2021 (+25.69 pp).
- Quarterly Net Margin has moved between -24.25% (Q4 2023) and 14.07% (Q2 2023) over five years.
- Compared with a year earlier, Net Margin was higher in four of the last seven quarters, with an average year-over-year change of +1.24 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q1 2022 (a gain of 35.68 percentage points); the worst was Q4 2023 (a drop of 25.19 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | International Stem Cell | 2.80 Mn | -1.17 Mn | 1.46 Mn | -2.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.65% |
| Dec 31, 2025 | -16.15% |
| Sep 30, 2025 | 1.22% |
| Jun 30, 2025 | 2.74% |
| Mar 31, 2025 | -12.02% |
| Dec 31, 2024 | 0.45% |
| Sep 30, 2024 | -5.74% |
| Jun 30, 2024 | 2.66% |
| Mar 31, 2024 | -10.05% |
| Dec 31, 2023 | -24.25% |
| Sep 30, 2023 | -6.64% |
| Jun 30, 2023 | 14.07% |
| Mar 31, 2023 | -1.63% |
| Dec 31, 2022 | 0.95% |
| Sep 30, 2022 | -20.14% |
| Jun 30, 2022 | -0.10% |
| Mar 31, 2022 | -0.45% |
| Dec 31, 2021 | -19.05% |
| Sep 30, 2021 | -8.96% |
| Jun 30, 2021 | 11.78% |
API Access
International Stem Cell Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();